Drug Type Small molecule drug |
Synonyms NTXOL, AIKO-150, AIKO-151 |
Target |
Action antagonists |
Mechanism μ opioid receptor antagonists(Mu opioid receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H25NO4 |
InChIKeyJLVNEHKORQFVQJ-PYIJOLGTSA-N |
CAS Registry49625-89-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Opioid abuse | Phase 1 | United States | 01 Mar 2009 | |
Unspecified drug dependence | Phase 1 | United States | 01 Mar 2009 | |
Opioid-Related Disorders | Clinical | - | 01 Dec 2011 |